Background: Diuretic use in acute kidney injury (AKI) is debatable. Contrasting outcomes have been reported regarding its efficacy in AKI. Sequential nephron blockade (SNB) has never been studied in a diverse ICU population admitted with AKI.Methods: Consecutive patients admitted to medical ICU with oliguric AKI over 1-year period were recruited. SNB as a diuretic strategy was administered. Responders (R) and non-responders (NR) were compared. Demographic data, clinical profile, treatment and outcomes were compared between the groups using t-test and Chi-square test as appropriate. Predictors of mortality were explored using bivariate and multivariate logistic regression analysis and expressed as Odds ratio (OR) with 95% confidence interval (CI). Results: Of the 331 ICU patients admitted with AKI, 312 patients received SNB. The mean (SD) age was 64.14±14·79 years with male preponderance (196:116). Admission SOFA score was significantly (p<0·001) higher (9.6±3.8) in non-responders than responders (6·3±3.6). Overall, 80.13% patients were responders and 19.6% patients received RRT. Significant difference (p<0·001) for diuretic response and dialysis were seen with pre-existing diabetes, higher KDIGO stage and SOFA score (>9) at ICU admission, sepsis, shock, mechanical ventilation, positive fluid balance, lengthy ICU stay and mortality. On multivariate logistic regression analysis, SOFA score >9(OR 4.50; 95%CI 2.30-8.80), negative diuretic response (OR 0.45; 95%CI 0.34-0.59), RRT need (OR 1.78; 95%CI 1.25-2.19) and a higher positive fluid balance (OR 2.82; 95%CI 1.76-3.89) were independently associated with death. Conclusions: SNB in oliguric AKI patients resulted in lesser need for dialysis and better outcomes. A negative response, need for dialysis and a higher positive fluid balance were independently associated with mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.